Literature DB >> 19746243

A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium.

Therese Heinonen1, David D Waters, Peter Libby, Jean-Claude Tardif.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19746243      PMCID： PMC2780899          DOI： 10.1016/s0828-282x(09)70143-6

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN： 0828-282X            Impact factor:   5.223


× No keyword cloud information.
  44 in total

1.  An uncertain future for cardiovascular drug development?

Authors:  Alan M Garber
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

2.  Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study.

Authors:  Shigeho Takarada; Toshio Imanishi; Takashi Kubo; Takashi Tanimoto; Hironori Kitabata; Nobuo Nakamura; Atsushi Tanaka; Masato Mizukoshi; Takashi Akasaka
Journal:  Atherosclerosis       Date:  2008-05-15       Impact factor: 5.162

3.  Diagnosis of human coronary atherosclerosis by morphology-based Raman spectroscopy.

Authors:  H P Buschman; J T Motz; G Deinum; T J Römer; M Fitzmaurice; J R Kramer; A van der Laarse; A V Bruschke; M S Feld
Journal:  Cardiovasc Pathol       Date:  2001 Mar-Apr       Impact factor: 2.185

4.  Correlation of carotid atheromatous plaque inflammation using USPIO-enhanced MR imaging with degree of luminal stenosis.

Authors:  Tjun Y Tang; Simon P S Howarth; Sam R Miller; Martin J Graves; Jean-Marie U-King-Im; Zhi-Yong Li; Stewart R Walsh; Andrew J Patterson; Peter J Kirkpatrick; Elizabeth A Warburton; Kevin Varty; Michael E Gaunt; Jonathan H Gillard
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

5.  Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.

Authors:  Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Josep Rodés-Cabau; Christopher P Cannon; John E Deanfield; Jean-Pierre Després; John J P Kastelein; Steven R Steinhubl; Samir Kapadia; Muhammad Yasin; Witold Ruzyllo; Christophe Gaudin; Bernard Job; Bo Hu; Deepak L Bhatt; A Michael Lincoff; E Murat Tuzcu
Journal:  JAMA       Date:  2008-04-01       Impact factor: 56.272

6.  Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque.

Authors:  Patrick W Serruys; Héctor M García-García; Pawel Buszman; Paul Erne; Stefan Verheye; Michael Aschermann; Henrikus Duckers; Oyvind Bleie; Dariusz Dudek; Hans Erik Bøtker; Clemens von Birgelen; Don D'Amico; Tammy Hutchinson; Andrew Zambanini; Frits Mastik; Gerrit-Anne van Es; Antonius F W van der Steen; D Geoffrey Vince; Peter Ganz; Christian W Hamm; William Wijns; Andrew Zalewski
Journal:  Circulation       Date:  2008-09-01       Impact factor: 29.690

Review 7.  Iron oxide particles for atheroma imaging.

Authors:  Tjun Y Tang; Karin H Muller; Martin J Graves; Zhi Y Li; Stewart R Walsh; Victoria Young; Umar Sadat; Simon P S Howarth; J H Gillard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-19       Impact factor: 8.311

8.  Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Cathy Anne Pinto; Christopher Tong; Ash Rafique; Richard Hargeaves; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

9.  Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Authors:  John J P Kastelein; Fatima Akdim; Erik S G Stroes; Aeilko H Zwinderman; Michiel L Bots; Anton F H Stalenhoef; Frank L J Visseren; Eric J G Sijbrands; Mieke D Trip; Evan A Stein; Daniel Gaudet; Raphael Duivenvoorden; Enrico P Veltri; A David Marais; Eric de Groot
Journal:  N Engl J Med       Date:  2008-03-30       Impact factor: 91.245

10.  Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.

Authors:  Menno Vergeer; Michiel L Bots; Sander I van Leuven; Dick C Basart; Eric J Sijbrands; Gregory W Evans; Diederick E Grobbee; Frank L Visseren; Anton F Stalenhoef; Erik S Stroes; John J P Kastelein
Journal:  Circulation       Date:  2008-11-24       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.